Table 2. Demographic and clinical information for patients and controls.
Vasculitis(n = 100) | Active(n = 19) | Remission(n = 81) | Disease Controls(n = 18) | Healthy Controls(n = 44) | |
---|---|---|---|---|---|
Age: Median (Range) | 59 (50–70) | 55 (51–73) | 59 (49–70) | 54 (17–87) | 39 (22–75) |
Gender | 51 male 49 female | 14 male 5 female | 37 male 44 female | 13 male 5 female | 19 male 25 female |
ANCA type at diagnosis | 17 anti-MPO 83 anti-PR3 | 7 anti-MPO 12 anti-PR3 | 10 anti-MPO 71 anti-PR3 | N/A | N/A |
Proportion of patients on immunosuppression | 72% | 76% | 72% | 65% | 0% |
Median CRP (mg/dL, interquartile range) | 3 (1–12) | 15(10–64) | 2 (1–7) | 9 (1–34) | N/A |
eGFR (ml/min, interquartile range) | 63 (42–80) | 49 (35–87) | 64 (42–80) | 64 (18–87) | N/A |
Proportion eGFR < 60 ml/min | 40% | 47% | 38% | 44% | N/A |
All clinical data were obtained on the same date as analysis of monocytes. CRP = C reactive protein.